ONCS - オンコセク・メディカル （OncoSec Medical Incorporated）

A share of OncoSec Medical Incorporated (NASDAQ:ONCS) closed at $2.08 per share on Tuesday, up from $1.68 day before. While OncoSec Medical Incorporated has overperformed by 23.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ONCS fell by -90.15%, with highs and lows ranging from $31.90 […]

OncoSec Medical Incorporated (NASDAQ:ONCS) has a beta value of 1.57 and has seen 1.84 million shares traded in the last trading session. The company, currently valued at $6.80M, closed the last trade at $2.08 per share which meant it gained $0.4 on the day or 23.81% during that session. The ONCS stock price is -1433.65% … OncoSec Medical Incorporated (ONCS) Is A Buy Stock For Small Caps – Analysts Read More »

OncoSec Medical Incorporated (NASDAQ:ONCS) marked $1.87 per share on Wednesday, up from a previous closing price of $1.61. While OncoSec Medical Incorporated has overperformed by 16.15%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ONCS fell by -92.54%, with highs and lows ranging from $31.90 to […]

In last trading session, OncoSec Medical Incorporated (NASDAQ:ONCS) saw 0.36 million shares changing hands with its beta currently measuring 1.52. Company’s recent per share price level of $1.71 trading at -$0.03 or -1.72% at ring of the bell on the day assigns it a market valuation of $3.54M. That closing price of ONCS’s stock is … OncoSec Medical Incorporated (NASDAQ:ONCS) Is Currently -1765.5% Below Its 52-Week High, But Downside Potential Could Surprise You. Read More »

OncoSec Medical''s (NASDAQ: ONCS ) short percent of float has risen 16200.0% since its last report. The company recently reported that it has 16 thousand shares sold short , which is 1.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 0.1 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price … Full story available on Benzinga.com

Horizon Therapeutics HZNP +28%. Check-Cap (CHEK) +14%. Aeglea BioTherapeutics AGLE -61%. OncoSec Medical ONCS -22%.

OncoSec Medical (ONCS) on Wednesday has priced its stock offering of 1.167M shares and accompanying warrants at $3 each. That is to amount the gross proceeds of about…

NEW YORK , Nov. 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APEN, ONCS, COSM, ZH, and BILI. … Full story available on Benzinga.com

In last trading session, OncoSec Medical Incorporated (NASDAQ:ONCS) saw 1.02 million shares changing hands with its beta currently measuring 1.64. Company’s recent per share price level of $3.73 trading at -$0.19 or -4.85% at ring of the bell on the day assigns it a market valuation of $7.65M. That closing price of ONCS’s stock is … OncoSec Medical Incorporated (NASDAQ:ONCS) Falls -4.85%, But An Additional Plunge May Follow. Read More »

OncoSec Medical Incorporated (NASDAQ:ONCS) traded at $3.90 at last check on Wednesday, November 23, made a downward move of -0.51% on its previous day’s price. Looking at the stock we see that its previous close was $3.92 and the beta (5Y monthly) reads 1.90 with the day’s price range being $3.91 – $6.4999. In terms … Is OncoSec Medical Incorporated (NASDAQ: ONCS) A Great Stock To Invest In? Read More »

OncoSec Medical issued its quarterly earnings results on Tuesday. The biotechnology company reported earnings per share for the quarter, topping the consensus estimate of by…

OncoSec Medical (ONCS) has appointed Robert Arch as President and CEO.Arch has over 28 years of experience, extending from academia to the pharmaceutical industry

OncoSec Medical Incorporated (ONCS) has appointed George Chi as Chief Financial Officer. Mr

OncoSec Medical Inc (ONCS) shares closed today 13.8% higher than it did at the end of yesterday. The stock is currently down 10.3% year-to-date, down 86.7% over the past 12 months, and down 93.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.4%. Trading Activity Shares traded as high as $1.07 and as low as $0.82 this week.Shares closed 88.0% below its 52-week high and 22.5% above its 52-week low.Trading volume this week was 26.8% lower than the 10-day average and 68.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 93.7% The company's stock price performance over the past 12 months lags the peer average by 116.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.